For example, the chemotherapy agent doxorubicin, in combination with Se, markedly decreased the proliferation, migration, and invasion, and increased the apoptosis of the EGFR and KRAS-activating mutant A549 lung adenocarcinoma cells as compared to doxorubicin alone [16]. Here, EGFR is linked to lung adenocarcinoma.